Clearpoint Neuro Inc
CLPT
View Detailed Chart
14.020USD
-0.470-3.24%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
398.56MMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-3.24%
5 Days
-1.27%
1 Month
-2.91%
6 Months
+18.81%
Year to Date
-8.84%
1 Year
-10.98%
View Detailed Chart
TradingKey Stock Score of Clearpoint Neuro Inc
Currency: USD Updated: 2025-12-26Key Insights
Clearpoint Neuro Inc's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 84/207 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 29.00.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Clearpoint Neuro Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Buy
Current Rating
29.000
Target Price
+111.83%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Clearpoint Neuro Inc Highlights
StrengthsRisks
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 52.74% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 31.39M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 31.39M.
Undervalued
The company’s latest PE is -16.96, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 11.91M shares, decreasing 0.01% quarter-over-quarter.
Held by Invesco
Star Investor Invesco holds 8.12K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.61.
Clearpoint Neuro Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Clearpoint Neuro Inc Info
ClearPoint Neuro, Inc. is a device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine. The Company provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The Company is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The Company also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
Ticker SymbolCLPT
CompanyClearpoint Neuro Inc
CEOBurnett (Joseph Michael)
Websitehttps://www.clearpointneuro.com/
FAQs
What is the current price of Clearpoint Neuro Inc (CLPT)?
The current price of Clearpoint Neuro Inc (CLPT) is 14.020.
What is the symbol of Clearpoint Neuro Inc?
The ticker symbol of Clearpoint Neuro Inc is CLPT.
What is the 52-week high of Clearpoint Neuro Inc?
The 52-week high of Clearpoint Neuro Inc is 30.100.
What is the 52-week low of Clearpoint Neuro Inc?
The 52-week low of Clearpoint Neuro Inc is 9.760.
What is the market capitalization of Clearpoint Neuro Inc?
The market capitalization of Clearpoint Neuro Inc is 398.56M.
What is the net income of Clearpoint Neuro Inc?
The net income of Clearpoint Neuro Inc is -18.91M.
Is Clearpoint Neuro Inc (CLPT) currently rated as Buy, Hold, or Sell?
According to analysts, Clearpoint Neuro Inc (CLPT) has an overall rating of Buy, with a price target of 29.000.
What is the Earnings Per Share (EPS TTM) of Clearpoint Neuro Inc (CLPT)?
The Earnings Per Share (EPS TTM) of Clearpoint Neuro Inc (CLPT) is -0.827.
Related Instruments
+1.30%
+0.29%
+0.03%
+0.11%
-0.49%
-0.05%
-0.13%
-0.75%
+0.67%
+0.59%
+1.91%
+0.59%
+0.34%
+0.09%
+0.04%
+0.64%
+0.26%
+0.05%
+0.26%
+0.67%Popular Symbols
